Editas Medicine (EDIT) Insider Trading & Ownership $2.45 +0.08 (+3.38%) (As of 11:30 AM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Editas Medicine (NASDAQ:EDIT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$253,800.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$1.10 M Get EDIT Insider Trade Alerts Want to know when executives and insiders are buying or selling Editas Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EDIT Insider Buying and Selling by Quarter Ad StockEarnings“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to pop now that Donald Trump has been re-electedClaim your copy before they move Editas Medicine Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/4/2024Baisong MeiEVPSell518$3.42$1,771.56 9/4/2024Gilmore Neil O'neillCEOSell1,555$3.42$5,318.10 7/25/2024Linda BurklyEVPSell11,886$5.42$64,422.12 7/19/2024Baisong MeiEVPSell6,619$5.21$34,484.99 6/4/2024Baisong MeiEVPSell511$5.50$2,810.50 6/4/2024Gilmore Neil O'neillCEOSell12,191$5.50$67,050.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/13/2024Jessica HopfieldDirectorBuy45,000$5.64$253,800.00 3/5/2024Gilmore Neil O'neillCEOSell77,824$9.42$733,102.08 3/4/2024Baisong MeiSVPSell20,327$9.42$191,480.34 12/5/2023Bruce EatonEVPSell103$10.90$1,122.70 (Data available from 1/1/2013 forward) EDIT Insider Trading Activity - Frequently Asked Questions Who is on Editas Medicine's Insider Roster? The list of insiders at Editas Medicine includes Baisong Mei, Bruce Eaton, Gilmore Neil O'neill, Jessica Hopfield, Linda Burkly, Mark S Shearman, and Michelle Robertson. Learn more on insiders at EDIT. What percentage of Editas Medicine stock is owned by insiders? 1.90% of Editas Medicine stock is owned by insiders. Learn more on EDIT's insider holdings. Which Editas Medicine insiders have been buying company stock? The following insider purchased EDIT shares in the last 24 months: Jessica Hopfield ($253,800.00). How much insider buying is happening at Editas Medicine? Insiders have purchased a total of 45,000 EDIT shares in the last 24 months for a total of $253,800.00 bought. Which Editas Medicine insiders have been selling company stock? The following insiders have sold EDIT shares in the last 24 months: Baisong Mei ($268,536.99), Bruce Eaton ($24,024.93), Gilmore Neil O'neill ($867,087.68), Linda Burkly ($64,422.12), Mark S Shearman ($26,979.30), and Michelle Robertson ($66,754.00). How much insider selling is happening at Editas Medicine? Insiders have sold a total of 154,739 Editas Medicine shares in the last 24 months for a total of $1,317,805.02 sold. Editas Medicine Key ExecutivesDr. Gilmore O'Neill M.D. (Age 60)President, CEO & Director Compensation: $1.04MMr. Erick J. Lucera C.F.A. (Age 56)CPA, CFO & Executive VP Compensation: $911.46kDr. Linda C. Burkly Ph.D. (Age 67)Executive VP & Chief Scientific Officer Compensation: $522.44kDr. Baisong Mei M.D. (Age 60)Ph.D., Executive VP & Chief Medical Officer Compensation: $654.9kDr. Feng Zhang Ph.D.Co-Founder & Scientific Advisory Board MemberDr. George McDonald Church Ph.D. (Age 70)Co-Founder & Scientific Advisory Board Member More Insider Trading Tools from MarketBeat Related Companies ADVM Insider Ownership BLUE Insider Ownership DTIL Insider Ownership SGMO Insider Ownership RGNX Insider Ownership PLRX Insider Ownership KURA Insider Ownership TYRA Insider Ownership PRTA Insider Ownership RLAY Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:EDIT) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
